Skip to Content

L350 (Desvenlafaxine Succinate Extended-Release 100 mg (base))

Pill with imprint L350 is Red, Round and has been identified as Desvenlafaxine Succinate Extended-Release 100 mg (base). It is supplied by Breckenridge Pharmaceutical, Inc..

Desvenlafaxine is used in the treatment of major depressive disorder; depression; adhd; anxiety; bipolar disorder (and more), and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Desvenlafaxine 100 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for L350

Desvenlafaxine Succinate Extended-Release

Imprint:
L350
Strength:
100 mg (base)
Color:
Red
Shape:
Round
Availability:
Prescription only
Drug Class:
Serotonin-norepinephrine reuptake inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Breckenridge Pharmaceutical, Inc.
National Drug Code (NDC):
51991-0312

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide